Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
暂无分享,去创建一个
J. Pugin | S. Harbarth | V. Nobre | P. Rohner | J. Graf
[1] Meta-analysis of procalcitonin for sepsis detection. , 2007, The Lancet. Infectious diseases.
[2] M. Christ-Crain,et al. Meta-analysis of procalcitonin for sepsis detection. , 2007, The Lancet. Infectious diseases.
[3] Anthony S McLean,et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. , 2007, The Lancet. Infectious diseases.
[4] J. Bartlett,et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] H. Goossens,et al. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study , 2007, The Lancet.
[6] S. Harbarth. [The effect of antimicrobial use on emergence and selection of resistance]. , 2007, Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS.
[7] H. Evans,et al. Cost of Gram‐negative resistance* , 2007, Critical care medicine.
[8] M. Christ-Crain,et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. , 2007, Chest.
[9] D. Pittet,et al. Does antibiotic selection impact patient outcome? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] J. Jensen,et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality* , 2006, Critical care medicine.
[11] M. Christ-Crain,et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. , 2006, American journal of respiratory and critical care medicine.
[12] M. Meisner,et al. Markers for sepsis diagnosis: what is useful? , 2006, Critical care clinics.
[13] Patrick Nicolas,et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis , 2006, Critical care medicine.
[14] C. Weenink,et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study , 2006, BMJ : British Medical Journal.
[15] J. le Gall,et al. SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort description , 2005, Intensive Care Medicine.
[16] Jonathan Cohen,et al. The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit , 2005, Critical care medicine.
[17] S. Hugonnet,et al. Long-term reduction of vascular access-associated bloodstream infection. , 2005, Annals of internal medicine.
[18] J. Vincent,et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.
[19] France Gauvin,et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] J. Rello,et al. Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality* , 2004, Critical care medicine.
[21] M. Christ-Crain,et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial , 2004, The Lancet.
[22] Michel Wolff,et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. , 2003, JAMA.
[23] K. Becker,et al. The future diagnostic role of procalcitonin levels: the need for improved sensitivity. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] S. Hugonnet,et al. Intensive care unit-acquired infections: Is postdischarge surveillance useful? , 2002, Critical care medicine.
[25] D. Pittet,et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. , 2001, American journal of respiratory and critical care medicine.
[26] S. Harbarth. Nosocomial transmission of antibiotic-resistant microorganisms , 2001, Current opinion in infectious diseases.
[27] S. Harbarth,et al. Variation in Antimicrobial Utilization for Febrile Neutropenia in Cancer Patients , 2000, Infection.
[28] M. Assicot,et al. High serum procalcitonin concentrations in patients with sepsis and infection , 1993, The Lancet.
[29] C. Sprung,et al. The ACCP-SCCM consensus conference on sepsis and organ failure. , 1992, Chest.